9/8/2025Baili and BMS Present Promising Data on EGFR/HER3 Bispecific ADC for F...

9/8/2025Atom Thera Achieves Positive Phase 2b/3 Trial Results for Lingdolinura...

9/8/2025NMPA Solicits Comments on Draft Guidelines for Online Prescription Dru...

9/8/2025NHSA Seeks Feedback on Draft Implementation Rules for Medical Insuranc...

9/5/2025BioNTech and DualityBio Score Phase III Win with Promising ADC in Brea...

9/5/2025How China Seeks to Solve Its Quality Control Conundrum (C&EN)

9/4/2025Baili-Bio Launches Phase 3 Trial for HER2-Targeted ADC in Gastric Canc...

9/3/2025Global Pharma Firms Pour $48 Billion into China in H1 2025, IQVIA Repo...

9/3/2025Sanofi China Receives Approval for Tzield to Delay Progression of Type...

9/3/2025China to Become World's Third-Largest Innovative Drug Market by 2028:...

9/3/2025Aon Report Highlights Rapid Growth and Challenges in China's Health In...

9/3/2025China's Biopharma Industry Clusters: Mapping Opportunities and Regiona...

9/3/2025China Biopharma Tracker – August 2025 (PharmaDJ)

9/2/2025Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...

9/2/2025Astellas Accelerates Growth and Innovation in China

8/30/2025CMS Subsidiary Gets Approval to Launch Clinical Trials of Povorctinib

8/30/2025Recent Executive Moves

8/29/2025NHSA Announces Results of Form Review for 2025 NRDL Submissions

8/29/2025CDE Solicits Comments on Draft Guideline for Post-Approval Change Mana...

8/29/2025Hengrui's SHR2554 Receives Conditional NMPA Approval

8/29/2025MagicRNA Raises ~CNY 100M in Pre-A+ Financing to Advance HN2301 Thera...

8/27/2025Tibet Rhodiola Bets Big on Cutting-Edge Gene-Editing Pioneer AccurEdit...

8/27/2025CRO ChemPartner to Open New Boston Research Hub in September

8/27/2025Royalty Pharma Targets China's Biotech Market with Early-Stage Investm...

8/27/2025Global Pharma Funnels $48.5B into Chinese Biotech Partnerships in H120...

8/27/2025AstraZeneca Bounces Back from Scandal in China with $2.5B R&D Push

8/26/2025InxMed Advances in Oncology with Upcoming IPO and Promising Pipeline

8/26/2025Simcere's Daridorexant Phase III Data Published and Approved in China

8/26/2025Akeso's Dual Phase III Victories Highlight Expansion of Non-Oncology T...

8/26/2025Akeso's Ivonescimab Secures First Demonstrated OS Benefit in Lung Can...

Page:7/372 Total number of articles:11155: [First][<<] [5] [6] [7] [8] [9] [>>] [End]